Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
MONTREAL, Nov. 16, 2011 /PRNewswire/ - Sunshine Biopharma Inc. (OTCBB: SBFM) a development stage pharmaceutical company focused on the research,...
- Sunshine Biopharma anuncia la finalización con éxito de sus estudios preclínicos de Adva-27a, el principal compuesto anticáncer de la compañía...
MONTREAL, Aug. 30, 2011 /PRNewswire/ - Sunshine Biopharma Inc. (OTCBB: SBFM) a development stage pharmaceutical company focused on the research,...
MONTREAL, July 11, 2011 /PRNewswire/ - Sunshine Biopharma Inc. (OTCBB: SBFM), a development stage pharmaceutical company focused on the research,...
MONTREAL, June 27, 2011 /PRNewswire/ - Sunshine Biopharma Inc. (OTCBB Ticker Symbol: SBFM) a development stage pharmaceutical company focused on the...
MONTREAL, June 17, 2011 /PRNewswire/ - Sunshine Biopharma, Inc. (OTCBB Ticker Symbol: SBFM) a development stage pharmaceutical company focused on the ...
MONTREAL, May 25, 2011 /PRNewswire/ - Advanomics Corporation, the parent company of Sunshine Biopharma Inc. (OTCBB Symbol: SBFM), is pleased to...
Company Will Present New Scientific Data at the Meeting April 2-6, 2011 In Orlando, Florida MONTREAL, April 1 /PRNewswire-FirstCall/ - Sunshine...
Parties to Work Together for Clinical Studies on Breast and Prostate Cancer Drug MONTREAL, Jan. 21 /PRNewswire-FirstCall/ - Sunshine Biopharma, Inc....
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.